|
1 |
1. Баркаган З.С., Момот А.П. Современные аспекты патогенеза, диагностики и терапии ДВС-синдрома // Вестн. гематол. 2005. Т. 1, № 2. 5-14 c. 2. Bennett J S. Platelet-fibrinogen interactions. //Ann N Y Acad Sci, 2001; 936. 340-354 c. 3. Brown AEX, Litvinov RI, Discher DE, Purohit PK, Weisel J W. Multiscale mechanics of fibrin polymer: gel stretching with protein unfolding and loss of water. //Science, 2009; 325(5941). 741-744c. 4. Byrnes JR, Duval C, Wang Y, et al. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking. //Blood, 2015; 126(16). 1940-1948 c. 5. Carr ME Jr. Development of platelet contractile force as a research and clinical measure of platelet function. //Cell Biochem Biophys, 2003; 38(1). 55-78 c. 6. Carr ME Jr, Martin EJ, Carr SL. Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation.// Blood Coagul Fibrinolysis, 2002;13(3). 193-197 c. 7. Carvalho FA, Connell S, Miltenberger-Miltenyi G, et al. Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes. //ACS Nano, 2010; 4(8). 4609-4620 c. 8. Cines DB, Lebedeva T, Nagaswami C, et al. Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin.// Blood, 2014; 123(10). 1596-1603 c. 9. Ehrlicher A, Hartwig JH. Cell mechanics: contracting to stiffness. //Nat Mater, 2011; 10(1). 12-13c. 10. Hartert H. Blutgerninnungstudien mit der thromboelastographic, einen neven untersuchingsver fahren // Klin Wochenschr, 1948. Vol. 26. P. 577–583 c. 11. Ilesanmi OO. Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy.// Hematol Rep, 2010; 2(1). 2 c. 12. Kasahara K, Souri M, Miki T, Yamamoto N, Ichinose A. Impaired clot retraction in factor XIII A subunit-deficient mice. //Blood, 2010; 115(6). 1277-1279 c. 13. Kasahara K, Kaneda M, Miki T, et al. Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts. //Blood, 2013; 122(19). 3340-3348 c. 14. Kim OV, Litvinov RI, Weisel JW, Alber MS. Structural basis for the nonlinear mechanics of fibrin networks under compression. //Biomaterials, 2014; 35(25). 6739-6749 c. 15. Kroll MH, Michaelis LC, Verstovsek S. Mechanisms of thrombogenesis in polycythemia vera. //Blood Rev, 2015; 29(4). 215-221 c. 16. Lam WA, Chaudhuri O, Crow A, et al. Mechanics and contraction dynamics of single platelets and implications for clot stiffening.// Nat Mater, 2011;10(1):61-66 c. 17. Léon C, Eckly A, Hechler B, et al. Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. //Blood, 2007; 110(9). 3183-3191c. 18. Litvinov RI, Gorkun OV, Owen SF, Shuman H, Weisel JW. Polymerization of fibrin: specificity, strength, and stability of knob-hole interactions studied at the single-molecule level. //Blood, 2005; 106(9). 2944-2951 c. 19. Maciaszek JL, Andemariam B, Lykotrafitis G. Microelasticity of red blood cells in sickle cell disease. //J Strain Anal Eng Des, 2011; 46(5). 368-379 c. 20. Mackman N. Triggers, targets and treatments for thrombosis. //Nature, 2008; 451(7181). 914-918 c. 21. Ono A,Westein E, Hsiao S, et al. Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth. //Blood, 2008; 112(1). 90-99 c. 22. Sutton JT, Ivancevich NM, Perrin SR Jr, Vela DC, Holland CK. Clot retraction affects the extent of ultrasound-enhanced thrombolysis in an ex vivo porcine thrombosis model. // Ultrasound Med Biol, 2013; 39(5). 813-824 c. 23. Whelihan MF, Mann KG. The role of the red cell membrane in thrombin generation. //Thromb Res, 2013; 131(5). 377-382 c. 24. Ząbczyk M, Sadowski M, Zalewski J, Undas A. Polyhedrocytes in intracoronary thrombi from patients with ST-elevation myocardial infarction.// Int J Cardiol, 2015;179. 186-187 c. |